Related Experiment Video

Updated: May 18, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Treatment of bacterial meningitis: an update

Seon Hee Shin1, Kwang Sik Kim

  • 1Johns Hopkins University School of Medicine, 200 North Wolfe Street, Room 3157, Baltimore, MD 21287, USA.

Expert Opinion on Pharmacotherapy
|September 19, 2012
PubMed
Abstract

Insights

Prompt antibiotic treatment is essential for bacterial meningitis. Optimal therapy requires bactericidal agents that cross the blood-brain barrier, with emerging antibiotics showing promise against resistant strains.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Pharmacology

Background:

  • Protein conjugate vaccines for Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis have altered bacterial meningitis epidemiology.
  • Bacterial meningitis remains a significant cause of mortality and morbidity, exacerbated by incomplete pathogenesis knowledge and antimicrobial resistance.
  • Early empiric antibiotic treatment is critical for managing bacterial meningitis patients.

Purpose of the Study:

  • To provide an overview of optimal treatment strategies for bacterial meningitis.
  • To discuss new insights into epidemiology, clinical and laboratory findings, and chemoprophylaxis.
  • To review antimicrobial resistance, new antibiotics, anti-inflammatory agents, adjunctive therapy, and pathogenesis.

Main Methods:

  • Literature review and synthesis of current knowledge on bacterial meningitis treatment.
  • Analysis of epidemiological data and clinical/laboratory findings.
  • Evaluation of antimicrobial agents, resistance patterns, and adjunctive therapies.

Main Results:

  • Optimal treatment necessitates bactericidal antibiotics penetrating the blood-brain barrier and effective in cerebrospinal fluid.
  • New antibiotics are available for resistant bacterial meningitis, but human study data is limited.
  • Understanding host-pathogen interactions is key to developing novel prevention and therapy strategies.

Conclusions:

  • Prompt and appropriate antibiotic administration is crucial for bacterial meningitis.
  • Effective treatment requires agents with bactericidal activity and good central nervous system penetration.
  • Further research into pathogenesis is needed for improved prevention and therapeutic approaches.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...